260 related articles for article (PubMed ID: 33244033)
1. Cell geometry and the cytoskeleton impact the nucleo-cytoplasmic localisation of the SMYD3 methyltransferase.
Pereira D; Richert A; Medjkane S; Hénon S; Weitzman JB
Sci Rep; 2020 Nov; 10(1):20598. PubMed ID: 33244033
[TBL] [Abstract][Full Text] [Related]
2. The SMYD3 methyltransferase promotes myogenesis by activating the myogenin regulatory network.
Codato R; Perichon M; Divol A; Fung E; Sotiropoulos A; Bigot A; Weitzman JB; Medjkane S
Sci Rep; 2019 Nov; 9(1):17298. PubMed ID: 31754141
[TBL] [Abstract][Full Text] [Related]
3. SMYD3 interacts with HTLV-1 Tax and regulates subcellular localization of Tax.
Yamamoto K; Ishida T; Nakano K; Yamagishi M; Yamochi T; Tanaka Y; Furukawa Y; Nakamura Y; Watanabe T
Cancer Sci; 2011 Jan; 102(1):260-6. PubMed ID: 21054678
[TBL] [Abstract][Full Text] [Related]
4. Regulation of nuclear architecture, mechanics, and nucleocytoplasmic shuttling of epigenetic factors by cell geometric constraints.
Alisafaei F; Jokhun DS; Shivashankar GV; Shenoy VB
Proc Natl Acad Sci U S A; 2019 Jul; 116(27):13200-13209. PubMed ID: 31209017
[TBL] [Abstract][Full Text] [Related]
5. Histone methyltransferase SMYD3 promotes MRTF-A-mediated transactivation of MYL9 and migration of MCF-7 breast cancer cells.
Luo XG; Zhang CL; Zhao WW; Liu ZP; Liu L; Mu A; Guo S; Wang N; Zhou H; Zhang TC
Cancer Lett; 2014 Mar; 344(1):129-137. PubMed ID: 24189459
[TBL] [Abstract][Full Text] [Related]
6. Histone methyltransferase Smyd3 regulates early embryonic lineage commitment in mice.
Suzuki S; Nozawa Y; Tsukamoto S; Kaneko T; Imai H; Minami N
Reproduction; 2015 Jul; 150(1):21-30. PubMed ID: 25918436
[TBL] [Abstract][Full Text] [Related]
7. Unveiling the Biochemistry of the Epigenetic Regulator SMYD3.
Fabini E; Talibov VO; Mihalic F; Naldi M; Bartolini M; Bertucci C; Del Rio A; Danielson UH
Biochemistry; 2019 Sep; 58(35):3634-3645. PubMed ID: 31389685
[TBL] [Abstract][Full Text] [Related]
8. SMYD3 stimulates EZR and LOXL2 transcription to enhance proliferation, migration, and invasion in esophageal squamous cell carcinoma.
Zhu Y; Zhu MX; Zhang XD; Xu XE; Wu ZY; Liao LD; Li LY; Xie YM; Wu JY; Zou HY; Xie JJ; Li EM; Xu LY
Hum Pathol; 2016 Jun; 52():153-63. PubMed ID: 26980013
[TBL] [Abstract][Full Text] [Related]
9. Regulated nuclear entry of over-expressed Setdb1.
Cho S; Park JS; Kang YK
Genes Cells; 2013 Aug; 18(8):694-703. PubMed ID: 23782009
[TBL] [Abstract][Full Text] [Related]
10. SMYD3 controls a Wnt-responsive epigenetic switch for ASCL2 activation and cancer stem cell maintenance.
Wang T; Wu H; Liu S; Lei Z; Qin Z; Wen L; Liu K; Wang X; Guo Y; Liu Q; Liu L; Wang J; Lin L; Mao C; Zhu X; Xiao H; Bian X; Chen D; Xu C; Wang B
Cancer Lett; 2018 Aug; 430():11-24. PubMed ID: 29746925
[TBL] [Abstract][Full Text] [Related]
11. Protein lysine methyltransferase SMYD3 is involved in tumorigenesis through regulation of HER2 homodimerization.
Yoshioka Y; Suzuki T; Matsuo Y; Tsurita G; Watanabe T; Dohmae N; Nakamura Y; Hamamoto R
Cancer Med; 2017 Jul; 6(7):1665-1672. PubMed ID: 28639750
[TBL] [Abstract][Full Text] [Related]
12. SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells.
Hamamoto R; Furukawa Y; Morita M; Iimura Y; Silva FP; Li M; Yagyu R; Nakamura Y
Nat Cell Biol; 2004 Aug; 6(8):731-40. PubMed ID: 15235609
[TBL] [Abstract][Full Text] [Related]
13. Lysine methylation in cancer: SMYD3-MAP3K2 teaches us new lessons in the Ras-ERK pathway.
Colón-Bolea P; Crespo P
Bioessays; 2014 Dec; 36(12):1162-9. PubMed ID: 25382779
[TBL] [Abstract][Full Text] [Related]
14. ATF7IP regulates SETDB1 nuclear localization and increases its ubiquitination.
Tsusaka T; Shimura C; Shinkai Y
EMBO Rep; 2019 Dec; 20(12):e48297. PubMed ID: 31576654
[TBL] [Abstract][Full Text] [Related]
15. SMYD3: An Oncogenic Driver Targeting Epigenetic Regulation and Signaling Pathways.
Bottino C; Peserico A; Simone C; Caretti G
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31935919
[TBL] [Abstract][Full Text] [Related]
16. The lysine 831 of vascular endothelial growth factor receptor 1 is a novel target of methylation by SMYD3.
Kunizaki M; Hamamoto R; Silva FP; Yamaguchi K; Nagayasu T; Shibuya M; Nakamura Y; Furukawa Y
Cancer Res; 2007 Nov; 67(22):10759-65. PubMed ID: 18006819
[TBL] [Abstract][Full Text] [Related]
17. Switching of cardiac troponin I between nuclear and cytoplasmic localization during muscle differentiation.
Kharitonov AV; Shubina MY; Nosov GA; Mamontova AV; Arifulin EA; Lisitsyna OM; Nalobin DS; Musinova YR; Sheval EV
Biochim Biophys Acta Mol Cell Res; 2020 Feb; 1867(2):118601. PubMed ID: 31733262
[TBL] [Abstract][Full Text] [Related]
18. Cytoskeletal to Nuclear Strain Transfer Regulates YAP Signaling in Mesenchymal Stem Cells.
Driscoll TP; Cosgrove BD; Heo SJ; Shurden ZE; Mauck RL
Biophys J; 2015 Jun; 108(12):2783-93. PubMed ID: 26083918
[TBL] [Abstract][Full Text] [Related]
19. Therapeutical potential of deregulated lysine methyltransferase SMYD3 as a safe target for novel anticancer agents.
Rajajeyabalachandran G; Kumar S; Murugesan T; Ekambaram S; Padmavathy R; Jegatheesan SK; Mullangi R; Rajagopal S
Expert Opin Ther Targets; 2017 Feb; 21(2):145-157. PubMed ID: 28019723
[TBL] [Abstract][Full Text] [Related]
20. Structural Basis for Substrate Preference of SMYD3, a SET Domain-containing Protein Lysine Methyltransferase.
Fu W; Liu N; Qiao Q; Wang M; Min J; Zhu B; Xu RM; Yang N
J Biol Chem; 2016 Apr; 291(17):9173-80. PubMed ID: 26929412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
